Back

PRIME Education, Inc. (PRIME®)

  • Atherosclerosis
  • Dyslipidemias

Translating Evidence Into Practice, Episode 1: Risk Stratification, LDL-C Targets, and Treatment Monitoring

Despite clear evidence that intensive LDL-C lowering reduces atherosclerotic cardiovascular disease (ASCVD) risk, many patients with established ASCVD or elevated risk remain above the recommended LDL-C targets. Accurate risk stratification, appropriate goal setting, and routine LDL-C assessment are essential to identifying treatment gaps and enabling timely intervention.Tune in to the first video podcast of this three-part series, developed from a live symposium presented at the 2026 ASPC Congress on CVD Prevention, as leading experts review the latest ACC/AHA recommendations for ASCVD risk assessment, LDL-C targets, and treatment monitoring. Through evidence-based discussion and audience Q&A, faculty explore common challenges in LDL-C management and share practical approaches for identifying patients who may benefit from treatment intensification.Stream the podcast video or the audio-only version and access downloadable educational resources designed to support guideline-directed LDL-C management and improve ASCVD risk reduction in daily practice.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Podcast / audio
  • includes Recorded-from-live session
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    Sep 19, 2026
  • Last day to claim credit
    Sep 19, 2027 11 months left